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Summary
Background Elimination of schistosomiasis as a public health problem and interruption of transmission in selected 
areas are targets set by WHO for 2025. Our aim was to assess biannual mass drug administration (MDA) applied 
alone or with complementary snail control or behaviour change interventions for the reduction of Schistosoma 
haematobium prevalence and infection intensity in children from Zanzibar and to compare the effect between 
the clusters.
Methods In a 5-year repeated cross-sectional cluster-randomised trial, 90 shehias (small administrative regions; 
clusters) in Zanzibar eligible owing to available natural open freshwater bodies and public primary schools were 
randomly allocated (ratio 1:1:1) to receive one of three interventions: biannual MDA with praziquantel alone (arm 1) 
or in combination with snail control (arm 2), or behaviour change activities (arm 3). Neither participants nor field or 
laboratory personnel were blinded to the intervention arms. From 2012 to 2017, annually, a single urine sample was 
collected from approximately 100 children aged 9–12 years in the main public primary school of each shehia. The 
primary outcome was S haematobium infection prevalence and intensity in 9–12-year-old children after 5 years of 
follow-up. This study is completed and was registered with the ISRCTN, number 48837681.
Findings The trial was done from Nov 1, 2011, through to Dec 31, 2017 and recruitment took place from Nov 2, 2011, 
until May 17, 2017. At baseline we enrolled 8278 participants, of whom 2899 (35%) were randomly allocated to arm 1, 
2741 (33%) to arm 2, and 2638 (32%) to arm 3. 120 (4·2%) of 2853 in arm 1, 209 (7·8%) of 2688 in arm 2, and 
167 (6·4%) of 2613 in arm 3 had S haematobium infections at baseline. Heavy infections (≥50 eggs per 10 mL of urine) 
were found in 126 (1∙6%) of 8073 children at baseline. At the 5-year endline survey, 46 (1·4%) of 3184 in arm 1, 
56 (1·7%) of 3217 (odds ratio [OR] 1∙2 [95% CI 0∙6–2∙7] vs arm 1) in arm 2, and 58 (1·9%) of 3080 (1∙3 [0∙6–2∙9]) in 
arm 3 had S haematobium infections. Heavy infections were detected in 33 (0∙3%) of 9462 children.
Interpretation Biannual MDA substantially reduced the S haematobium prevalence and infection intensity but was 
insufficient to interrupt transmission. Although snail control or behaviour change activities did not significantly 
boost the effect of MDA in our study, they might enhance interruption of transmission when tailored to focal 
endemicity and applied for a longer period. It is now necessary to focus on reducing prevalence in remaining hotspot 
areas and to introduce new methods of surveillance and public health response so that the important gains can be 
maintained and advanced.
Funding University of Georgia Research Foundation Inc and Bill & Melinda Gates Foundation.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Schistosomiasis is a parasitic disease caused by 
infection with blood flukes of the genus Schistosoma.1 
An estimated 800 million people are at risk of infection 
and more than 200 million people are infected.2 In 2016, 
the global burden of schistosomiasis was 1·86 million 
disability-adjusted life years.3 Over the past 15 years, 
substantial progress has been made in the control of 
schistosomiasis. There has been a shift from morbidity 
control towards elimination in selected areas and new 
targets have been issued by WHO: elimination of 
schistosomiasis as a public health problem (prevalence 
of heavy intensity infections below 1% in all sentinel 
sites) and interruption of transmission (reduction of 
incidence of infection to zero) in selected areas by 
2025.1,4 The Zanzibar archipelago, offshore from 
Tanzania, is one of the first settings in sub-Saharan 
Africa targeted for elimination of urogenital schisto-
somiasis as a public health problem and interruption of 
transmission.
The cornerstone of schistosomiasis control is mass 
drug administration (MDA) with praziquantel, but 
moving towards elimination will require complementary 
measures.4–6 Suggested measures to reach interruption 
of transmission in selected areas where transmission 
is low and highly focal include intensified treatment 
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(ie, treatment intervals shorter than 12 months and 
targeting not only school-aged but also preschool-aged 
children and adults, including women of reproductive 
age) plus intermediate host snail control, improvements 
in access to clean water, sanitation, and hygiene (WASH) 
to reduce and ideally impede the contamination of 
freshwater bodies, and interventions to assist people in 
changing their behaviour to prevent transmission and 
infection.4,7–10
Our objectives were to assess biannual MDA applied 
alone or with complementary snail control or behaviour 
change interventions for the reduction of Schistosoma 
haematobium prevalence and infection intensity in 
children from Zanzibar and to compare the effect 
between the clusters.
Methods
Study design and participants
The Zanzibar archipelago consists of two main islands: 
Pemba and Unguja. Each island is divided into districts, 
which are subdivided into small administrative units 
called shehias. In 2012, the national census recorded 
121 shehias in Pemba and 210 shehias in Unguja. The 
total population is estimated at 1·3 million. Urogenital 
schistosomiasis caused by infection with S haematobium 
has been highly prevalent in the past century, with 
prevalences exceeding 50% in some places, but was 
reduced to an overall prevalence below 10% in 2012.11–14 It 
is hence important to note that our trial was done in a 
setting that had been exposed to MDA with praziquantel 
for several years and that our baseline population in 2012 
was mostly not naive to treatment.13
The study was a 5-year cluster-randomised open-label 
trial with three intervention arms. The study design has 
been published elsewhere.15 We included children aged 
9–12 years. From 2012 to 2017, annually, a single urine 
sample was collected from approximately 100 children 
aged 9–12 years in the main public primary school of 
each of the 90 study shehias. A shehia was defined as the 
cluster and intervention unit. The trial was done in 
90 shehias on Pemba and Unguja, from Nov 1, 2011, 
through to Dec 31, 2017, and recruitment took place 
from Nov 2, 2011, until May 17, 2017. Interventions in all 
arms started within one year after the baseline survey in 
2012 and were intensified until the endline survey in 
early 2017. The first community-wide treatment MDA 
round was conducted on April 28, 2012. Snail control 
started on Aug 1, 2012. Behaviour change interventions 
started in a phase-in approach from Nov 1, 2012.
Ethical approval was obtained from the Zanzibar Medical 
Research Ethics Committee in Stonetown, Zanzibar 
(ZAMREC; reference no. ZAMREC 0003/Sept/011), the 
Research in context
Evidence before this study
Elimination of schistosomiasis has been shown to be feasible. 
In 2011, the 56th World Health Assembly called on all countries 
endemic for schistosomiasis to intensify control interventions 
and to strengthen surveillance, with the aim of eliminating the 
disease. In 2012, WHO set elimination of schistosomiasis as a 
public health problem and interruption of transmission in 
selected areas as targets for 2025. Countries having achieved 
interruption of transmission reported economic improvements, 
the integrated use of mass drug administration (MDA), 
intermediate host snail control, or improved access to clean 
water, sanitation, and hygiene. A large-scale concurrent 
research trial of strategies to control Schistosoma mansoni done 
in St Lucia from 1965 to 1981 showed best results when 
chemotherapy was supplemented by snail control or new 
household level water supplies. Meta-analyses highlight that 
control of intermediate host snails can contribute significantly 
to moving towards schistosomiasis elimination in high-risk 
areas. However, evidence for strategic decisions based on 
results from randomised trials is absent.
Added value of this study
We did a 5-year cluster-randomised trial to assess the effect of 
different interventions for elimination of urogenital 
schistosomiasis as a public health problem and interruption of 
transmission. Biannual MDA with praziquantel was offered to all 
age groups with the exception of children below the age of 
3 years across the Zanzibar islands. New behavioural 
interventions were developed in a human centred design 
approach and applied in randomised communities. The capacity 
for snail control was established. In randomised communities, 
water bodies containing intermediate host snails were targeted 
by focal mollusciciding. Our trial showed that biannual MDA 
applied alone or in combination with snail control or behaviour 
change activities can substantially reduce the overall 
Schistosoma haematobium prevalence and infection intensity. 
Urogenital schistosomiasis was eliminated as a public health 
problem from Zanzibar in more than 90% of the shehias 
included in the study, but transmission is not yet interrupted 
and reinfection occurs. Although randomised additional 
interventions in our study did not significantly boost the effect 
of MDA, they might enhance interruption of transmission when 
tailored to focal endemicity and applied for a longer period.
Implications of all the available evidence
Schistosomiasis is a focal disease. In settings where elimination 
as a public health problem and interruption of transmission is 
the goal, intervention strategies need to be tailored to the local 
micro-epidemiology and culture. It is now necessary to build on 
the experience gained in this trial and other studies, to focus on 
reducing prevalence and intensity in remaining hotspot areas, 
and to introduce new methods of rigorous surveillance, 
followed by specific public health response so that the 
important gains can be maintained and advanced.
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Ethikkommission beider Basel (EKBB) in Basel, 
Switzerland (reference no. 236/11) and the Institutional 
Review Board of the University of Georgia in Athens, GA, 
USA (project no. 2012-10138-0). Written informed consent 
was obtained from the parents or guardians of 
participating children.
Randomisation and masking
Stratified by island, shehias were randomly allocated to 
one of three intervention arms (ratio 1:1:1), as described 
elsewhere.15 In brief, 15 shehias on each island received 
biannual MDA with praziquantel administered by the 
Neglected Tropical Diseases (NTD) Programme of the 
Zanzibar Ministry of Health across the archipelago 
(arm 1); 15 shehias received snail control in addition 
to biannual MDA (arm 2); and 15 shehias received 
behaviour change interventions in addition to biannual 
MDA (arm 3). Owing to the nature of the intervention, 
neither participants nor field or laboratory personnel 
were blinded to the intervention arms.
Outcomes
The primary outcome was S haematobium infection 
prevalence and intensity in 9–12-year-old children in 
Zanzibar in 2017 after 5 years of follow-up at individual 
and cluster level. The primary outcome was reworded 
after registration of the study to meet the appropriate 
definition of a variable16 and to point out the main trial 
population. The change in the primary outcome was 
based on the recommendation of trialists who supported 
the preparation of the statistical analysis plan (appendix) 
and decided upon by the trial leadership and the 
Schistosomiasis Consortium for Operational Research 
and Evaluation (SCORE) secretariat. The decision to 
reword the primary outcome was done before the 
statistician had access to the data for analysis. Secondary 
outcomes including the S haematobium prevalence and 
intensity in first-year students and adults are presented 
elsewhere.17 No outcomes were excluded from the 
analyses.
Procedures
The baseline survey was done in the primary schools of 
the 90 study shehias in early 2012, with annual follow-
up surveys done in early 2013, 2014, 2015, 2016, and 
2017. The purpose and procedures of the study were 
explained to eligible children. Once we received the 
informed consent form signed by the parents or 
guardians, the participants were provided with a plastic 
container and instructions for urine collection between 
09:00 h and 14:00 h the following day. A single urine 
sample from each participant was transferred to the 
laboratory of the NTD Programme in Unguja or to the 
Public Health Laboratory—Ivo de Carneri in Pemba. 
Each urine sample of sufficient quantity was visually 
examined for macrohaematuria, for microhaematuria 
by means of reagent strips (Haemastix; Siemens 
Healthcare Diagnostics GmbH, Camberley, Surrey, 
UK), and for S haematobium eggs, by means of the 
filtration method.17 10% of all urine samples were re-
read by a senior laboratory technician for quality control. 
In the months following the survey, MDA was done in 
schools and communities and praziquantel (40 mg/kg) 
was offered to the whole eligible population. Treatment 
coverage data were collected as described elsewhere in 
detail.18
Praziquantel was administered biannually across both 
islands, in all shehias located in Pemba and Unguja, with 
the exception of the South district and the Urban A and B 
subdistricts in Unguja.17 In community-wide treatment 
(CWT), implemented twice per year from April, 2012 
onward, praziquantel was distributed by trained 
community drug distributors (CDDs) to the whole 
eligible population, excluding children younger than 
3 years, children treated during school-based treatment 
(SBT), severely sick people, and pregnant women.18 In 
additional SBT, implemented for the first time in MDA 
round 4, praziquantel was administered to schoolchildren 
by teachers by means of a dose pole and the intake of 
drugs was directly observed. Data on treatment coverage 
of CWT was collected from the records of CDDs and of 
SBT from teachers, by staff of the Zanzibar Ministry of 
Figure 1: Trial profile 
Shehia=small administrative region. MDA=mass drug administration.
90 shehias randomly allocated 
291 shehias assessed for eligibility 
201 shehias excluded
196 did not meet inclusion criteria 
5 randomly excluded
Arm 3: biannual MDA plus 
behaviour change
30 shehias and schools allocated 
to intervention
30 shehias or schools received 
allocated intervention
29 allocated schools were 
surveyed at baseline
1 allocated school was not 
surveyed at baseline
1 not randomly allocated 
school was surveyed
1 school discontinued 
intervention
29 schools were surveyed at 
endline 
Arm 2: biannual MDA plus 
snail control
30 shehias and schools allocated 
to intervention
30 shehias or schools 
received allocated 
intervention
29 allocated schools were 
surveyed at baseline
1 allocated school was 
not surveyed at baseline
1 not randomly 
allocated school was 
surveyed
0 schools lost to follow-up or 
discontinued intervention
30 schools were surveyed at 
endline 
30 schools analysed 30 schools analysed 
Arm 1: biannual MDA 
30 shehias or schools allocated 
to intervention
30 shehias and schools 
received allocated 
intervention
30 schools were surveyed 
at baseline
0 schools lost to follow-up or 
discontinued intervention
30 schools were surveyed at 
endline 
30 schools analysed 
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Health. Our project staff collected additional data on 
treatment coverage and compliance during the annual 
cross-sectional surveys in schools and communities.16,18
For snail control activities, human water contact sites 
(HWCSs) were identified in the 30 study shehias before 
and over the course of the trial with the help of local 
knowledge and information. Trained teams did surveys 
for intermediate host snails (Bulinus spp) at each HWCS 
multiple times per year outside of the heavy rainy season. 
For this purpose, approximately 15 m of the shoreline 
were measured and searched for snails of all species by 
two collectors for 15 min, using their hands and snail 
scoops.19 The molluscicide niclosamide (Bayluscide; 
donated by Bayer SAS, Monheim, Germany) was sprayed 
at HWCSs only if Bulinus spp were present.17 Niclosamide 
wettable powder was mixed with pond water (according 
to manufacturer’s instructions) and applied to the 
shoreline around the HWCS with Hudson backpack 
sprayers or a petrol power spraying machine, depending 
on the environment. The HWCS’s location, type, water 
chemistry, presence of snails, and niclosamide spraying 
were recorded at each survey.
Community co-designed behaviour change interventions 
were developed and implemented in the 30 study shehias 
in a staggered approach by trained teams.20 Classroom-
based and school-wide intervention components were 
done by trained primary school teachers and religious 
school teachers using culturally tailored, interactive tools, 
materials, and engagement methods developed within the 
programme (eg, flipcharts, blood fluke pictures, snail 
boards, and self-drawing of schistosome life-cycles) to 
teach children about schistosomiasis transmission and 
prevention.20,21 Teachers and children did regularly, school-
wide, Kichocho Day Events incorporating dramas, poems, 
and games that focused on schistosomiasis transmission, 
prevention, and treatment. Parents and other community 
members were encouraged to participate in Kichocho 
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Figure 2: Timeline of interventions and surveys
SBT=school-based treatment. CWT=community-wide treatment. *In Pemba, in round 6, community-wide treatment was done by means of health posts.
Biannual MDA Biannual MDA plus 
snail control
Biannual MDA plus 
behaviour change
Schools* 30 29 29
Pemba 15 15 15
Unguja 15 14 14
Total participants 2899 2741 2638
Pemba 1454 (50·2%) 1308 (47·7%) 1320 (50·0%)
Unguja 1445 (49·8%) 1433 (52·3%) 1318 (50·0%)
Mean age in years (SD) 10·5 (1·0) 10·5 (1·0) 10·5 (1·0)
Pemba 10·6 (0·9) 10·7 (1·0) 10·6 (1·0)
Unguja 10·4 (1·0) 10·4 (1·0) 10·4 (1·0)
Sex
Overall
Girls 1569 1461 1410
Boys 1330 1280 1228
Pemba
Girls 822 694 720
Boys 632 614 600
Unguja
Girls 747 767 690
Boys 698 666 628
Participants with outcome data 2853 2688 2613
Pemba 1437 (50·4%) 1276 (47·5%) 1304 (49·9%)
Unguja 1416 (49·6%) 1412 (52·5%) 1309 (50·1%)
Schistosoma haematobium 
infection†
120/2853 (4·2%) 209/2688 (7·8%) 167/2613 (6·4%)
Pemba 71/1437 (4·9%) 141/1276 (11·1%) 116/1304 (8·9%)
Unguja 49/1416 (3·5%) 68/1412 (4·8%) 51/1309 (3·9%)
Arithmetic mean number of 
eggs per 10 mL of urine
2·8 5·7 5·3
Pemba 5·0 10·2 9·6
Unguja 0·6 1·6 1·1
(Table 1 continues on next page)
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Day Events and interactive health education activities. 
Community-based interventions included community 
meetings, evening educational films, and the construction 
of one male and one female urinal per shehia near a 
freshwater body with known schistosomiasis transmission. 
In the second half of the project, community co-designed 
washing platforms were constructed in close proximity to a 
safe water source in behavioural shehias with the highest 
disease prevalence. Data on school census and children 
exposed to the interventions as well as community 
intervention components were collected over the course of 
the implementation process.
Statistical analysis
The sample size calculation, eligibility criteria, and 
randomisation procedures of clusters and study partici-
pants are described in the published study protocol.15 In 
brief, to reach a desired power of 80%, the sample size of 
clusters (ie, shehias) exceeded the total number of 
schistosomiasis-endemic shehias in Unguja and Pemba 
and the sample size of participants was logistically 
not feasible. Hence, the choice of 15 shehias per 
intervention arm per island, and the number of people 
to be tested was a compromise between what was 
considered optimal and what was practically achievable. 
Participants were considered S haematobium-positive 
if the urine filtration method revealed at least one 
S haematobium egg per 10 mL urine, or, in the absence of 
a urine filtration result, if microhaematuria was detected 
with reagent strips. Infection intensities were classified 
into light (1–49 eggs per 10 mL urine) and heavy (≥50 eggs 
per 10 mL urine) according to WHO thresholds.22 Egg 
counts were truncated at 1000 eggs per 10 mL urine.
The absolute and relative difference (% change) in the 
S haematobium prevalence at baseline in 2012 and endline 
in 2017 were calculated. Arithmetic mean (AM) egg counts, 
including zeros, were calculated at baseline and endline as 
a proxy for transmission force at shehia level; AM egg 
counts, excluding zeros, were calculated at baseline and 
endline as a proxy for transmission force at individual 
level. The AM egg reduction rate from 2012 to 2017 was 
calculated by means of the following formula: 1−AM egg 
counts in 2017/AM egg counts in 2012. Generalised 
estimating equation models with binary logit functions 
and negative binomial distributed outcomes with log link 
functions, and independent correlation structure were 
applied to compare trial arms. All models used robust 
variance estimators to account for correlation within 
clusters (ie, the school). Biannual MDA alone was the 
designated reference group. For unadjusted estimates, 
only infection status (as outcome) and treatment arm were 
included in the model. In the adjusted analysis, sex and 
age were included in the model as explanatory variables. In 
addition, the observations in the adjusted analysis were 
weighted by the inverse cluster size (probability weights), 
which ensures that each cluster contributes equally to the 
generalised estimating equation, regardless of its size. 
Biannual MDA Biannual MDA plus 
snail control
Biannual MDA plus 
behaviour change
(Continued from previous page)
Infection intensity‡
Overall
Negative 2712/2830 (95·8%) 2451/2658 (92·2%) 2422/2585 (93·7%)
Light 93/2830 (3·3%) 158/2658 (5·9%) 111/2585 (4·3%)
Heavy 25/2830 (0·9%) 49/2658 (1·8%) 52/2585 (2·0%)
Pemba
Negative 1363/1433 (95·1%) 1133/1274 (88·9%) 1182/1297 (91·1%)
Light 47/1433 (3·3%) 102/1274 (8·0%) 70/1297 (5·4%)
Heavy 23/1433 (1·6%) 39/1274 (3·1%) 45/1297 (3·5%)
Unguja
Negative 1349/1397 (96·5%) 1318/1384 (95·2%) 1240/1288 (96·2%)
Light 46/1397 (3·3%) 56/1384 (4·0%) 41/1288 (3·2%)
Heavy 2/1397 (0·1%) 10/1384 (0·7%) 7/1288 (0·5%)
Data are number (%), or n/N (%), unless otherwise stated. MDA=mass drug administration. SD=standard deviation. 
*One school in the biannual MDA plus snail control group and one school in the biannual MDA plus behaviour change 
group were not surveyed at baseline. †S haematobium-positive is defined as urine filtration egg-positive or, in the 
absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++). ‡The intensity of S haematobium 
infection was categorised as negative (0 eggs per 10 mL of urine), light (1–49 eggs per 10 mL of urine), or heavy 
(≥50 eggs per 10 mL of urine).
Table 1: Baseline demographic and clinical characteristics
Biannual MDA Biannual MDA 
plus snail 
control
Biannual MDA 
plus behaviour 
change
Overall
Clusters at baseline 30 29 29 88
Tested at baseline with urine filtration 
and reagent strips*
2853 2688 2613 8154
Tested at baseline with urine filtration* 2830 2658 2585 8073
Tested at baseline with reagent strips* 2852 2681 2613 8146
Infected at baseline* 120 209 167 496
Heavy infection intensity at baseline† 25 49 52 126
Prevalence at baseline* 4·2% 7·8% 6·4% 6·1%
Heavy infection intensity at baseline† 0·9% 1·8% 2·0% 1·6%
Clusters at year 6 30 30 29 89
Tested in year 6 with urine filtration 
and reagent strips*
3184 3217 3080 9481
Tested in year 6 with urine filtration* 3171 3213 3078 9462
Tested in year 6 with reagent strips* 3183 3198 3078 9459
Infected in year 6* 46 56 58 160
Heavy infection intensity in year 6† 12 8 13 33
Prevalence in year 6* 1·4% 1·7% 1·9% 1·7%
Heavy infection intensity in year 6† 0·4% 0·3% 0·4% 0·4%
Absolute difference between 
prevalence at year 6 and baseline*
−2·8 −6·0 −4·5 −4·4
Relative difference between prevalence 
in year 6 and baseline (% change)*
−65·7% −77·6% −70·5% −72·3%
Village level arithmetic mean infection 
intensity at baseline (including zero egg 
counts)†
2·8 6·3 5·0 4·7
Village level arithmetic mean infection 
intensity at year 6 (including zero egg 
counts)†
1·0 1·0 1·5 1·2
(Table 2 continues on next page)
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Intra-class correlation was established by means of mixed 
models consistent with the generalised estimating 
equation, setup in the primary analysis.
Given the relatively high number of clusters, balance 
in baseline characteristics was a reasonable assumption. 
Since we detected some discrepancy in baseline 
prevalence among the three trial arms, we comple-
mented the results with an exploratory analysis using 
different types of adjustment for baseline prevalence. 
Treatment coverage was calculated as described 
elsewhere in detail.18
Descriptive statistics were done by means of Stata IC 14 
(StataCorp; College Station, TX, USA), the primary analyses 
and interaction models by SAS version 9.4 and the inverse 
probability weight model was fitted by the ipw package of 
R version 3.4.3 by two of the authors (SK and JH).
Figure 3: Schistosoma haematobium prevalence in 45 schools on each of the two study islands from 
2012 to 2017
Colours from red to green indicate the change in prevalence from high to low. Letters indicate the three different 
study arms. M=biannual praziquantel mass drug administration (MDA) only. B=behaviour change plus biannual 
praziquantel MDA. S=snail control plus biannual praziquantel MDA.
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OR/CR 95% CI p value
Primary analysis
Prevalence 2017
Unadjusted (n=9481)
MDA 1·0 (ref) ·· ··
MDA + snail control 1·21 0·6–2·7 0·64
MDA + behaviour 
change
1·31 0·6–2·9 0·50
Adjusted (n=9481)*
MDA 1·0 (ref) ·· ··
MDA + snail control 1·19 0·5–2·6 0·66
MDA + behaviour 
change
1·44 0·7–3·1 0·38
Egg counts 2017
Unadjusted (n=9462)
MDA 1·0 (ref) ·· ··
MDA + snail control 0·93 0·3–3·3 0·91
MDA + behaviour 
change
1·35 0·4–4·4 0·62
Adjusted (n=9462)*
MDA 1·0 (ref) ·· ··
MDA + snail control 0·96 0·3–3·3 0·94
MDA + behaviour 
change
1·80 0·6–6·0 0·32
Exploratory analysis
Prevalence 2012 vs 2017
Intervention × year (n=17 635)†
MDA 1·0 (ref) ·· ··
MDA + snail control 0·63 0·4–1·1 0·13
MDA + behaviour 
change
0·84 0·5–1·6 0·60
Prevalence 2017
Adjusted baseline prevalence (n=9250)
MDA 1·0 (ref) ·· ··
MDA + snail control 0·64 0·3–1·3 0·17
MDA + behaviour 
change
0·82 0·4–1·9 0·65
Inverse probability weights (n=9250)‡
MDA 1·0 (ref) ·· ··
MDA + snail control 0·65 0·3–1·5 0·31
MDA + behaviour 
change
1·06 0·5–2·5 0·95
OR=odds ratio. CR=count ratios. *Sex and age are also included in the model, 
along with weighting for number of children who provided data, because not all 
schools were able to sample 100 children aged 9–12-years. †Baseline year (2012) 
is the reference. ‡Clusters are inversely weighted by their baseline prevalence as 
continuous variables.
Table 3: (Un)adjusted ORs of prevalence and count ratios for infection 
intensity
Biannual MDA Biannual MDA 
plus snail 
control
Biannual MDA 
plus behaviour 
change
Overall
(Continued from previous page)
Egg reduction rate (1–year 6 
intensity at baseline)†
0·6 0·8 0·7 0·8
Individual-level arithmetic mean 
infection intensity at baseline 
(excluding zero egg counts)†
68·0 73·5 84·6 75·9
Individual-level arithmetic mean 
infection intensity at year 6 (excluding 
zero egg counts)†
75·4 58·5 78·4 70·6
MDA=mass drug administration. *Schistosoma haematobium-positive is defined as urine filtration egg-positive or, in 
the absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++). †The intensity of S haematobium 
infection was categorised as negative (0 eggs per 10 ml of urine), light (1–49 eggs per 10 mL of urine), or heavy 
(≥50 eggs per 10 mL of urine).
Table 2: Reduction of Schistosoma haematobium prevalence and intensity from baseline (2012) to endline 
(2017)
For more on the R Project see 
http://www.r-project.org
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Shehias 
with 
schools*
School- 
children 
registered 
in school*
School-
children 
treated*
School- 
children 
treated* 
(%)
School- 
children 
surveyed†
School- 
children 
treated†
School- 
children 
treated† 
(%)
Shehias* Total 
population*
Total 
population 
treated*
Total 
population 
eligible for 
treatment*
Total 
population 
treated* 
(%)
2012
MDA round 1
MDA ·· ·· ·· ·· ·· ·· ·· 31 116 746 99 187 ·· 85·0%
MDA + snail control ·· ·· ·· ·· ·· ·· ·· 31 118 596 97 744 ·· 82·4%
MDA + behaviour change ·· ·· ·· ·· ·· ·· ·· 30 137 953 105 450 ·· 76·4%
MDA round 2
MDA ·· ·· ·· ·· ·· ·· ·· 31 147 511 122 100 ·· 82·8%
MDA + snail control ·· ·· ·· ·· ·· ·· ·· 31 127 429 104 634 ·· 82·1%
MDA + behaviour change ·· ·· ·· ·· ·· ·· ·· 30 136 698 118 409 ·· 86·6%
2013
MDA round 3
MDA ·· ·· ·· ·· ·· ·· ·· 30 121 089 88 261 99 511 72·9%
MDA + snail control ·· ·· ·· ·· ·· ·· ·· 31 119 681 91 732 104 918 76·6%
MDA + behaviour change ·· ·· ·· ·· ·· ·· ·· 30 118 809 87 221 101 752 73·4%
MDA round 4
MDA 25 18 022 13 011 72·2% 3221 2368 73·5% 31 151 775 79 993 95 440 52·7%
MDA + snail control 23 13 007 9748 74·9% 3262 2276 69·8% 31 128 311 88 621 112 615 69·1%
MDA + behaviour change 24 25 289 19 220 76·0% 3164 2535 80·1% 30 127 390 88 512 108 168 69·5%
2014
MDA round 5
MDA ·· ·· ·· ·· ·· ·· ·· 31 128 381 84 837 100 029 66·1%
MDA + snail control ·· ·· ·· ·· ·· ·· ·· 31 135 072 96 332 115 553 71·3%
MDA + behaviour change ·· ·· ·· ·· ·· ·· ·· 30 139 888 91 931 116 218 65·7%
MDA round 6
MDA 15 13 023 11 155 85·7% 3276 2661 81·2% 15 61 932 40 419 47 644 65·3%
MDA + snail control 14 9775 7457 76·3% 3365 2702 80·3% 15 103 447 65 950 80 318 63·8%
MDA + behaviour change 15 17 433 14 058 80·6% 3230 2709 83·9% 15 66 864 45 481 56 290 68·0%
2015
MDA round 7
MDA 31 37 374 31 454 84·2% ·· ·· ·· 31 123 317 68 236 88 501 55·3%
MDA + snail control 31 40 969 30 999 75·7% ·· ·· ·· 31 138 000 83 869 109 957 60·8%
MDA + behaviour change 29 40 653 32 045 78·8% ·· ·· ·· 30 129 842 75 649 98 539 58·3%
MDA round 8
MDA 31 49 360 36 810 74·6% 3298 3052 92·5% 31 106 996 73 832 93 540 69·0%
MDA + snail control 31 43 405 32 948 75·9% 3398 3172 93·3% 31 126 034 89 604 114 197 71·1%
MDA + behaviour change 30 47 702 35 818 75·1% 3114 2872 92·2% 30 114 038 79 227 101 873 69·5%
2016
MDA round 9
MDA 31 40 233 35 033 87·1% ·· ·· ·· 31 120 178 48 779 84 304 40·6%
MDA + snail control 31 42 653 35 995 84·4% ·· ·· ·· 31 128 345 45 045 90 304 35·1%
MDA + behaviour change 30 50 930 42 862 84·2% ·· ·· ·· 30 115 166 49 222 83 809 42·7%
MDA round 10
MDA 30 42 545 38 430 90·3% 3192 3126 97·9% 31 121 190 74 976 90 234 61·9%
MDA + snail control 30 45 660 39 098 85·6% 3236 3158 97·6% 30 138 817 892 77 107 045 64·3%
MDA + behaviour change 30 51 386 46 469 90·4% 3093 3034 98·1% 30 134 410 79 978 95 689 59·5%
MDA=mass drug administration. *Ministry of Health data. †Cluster-randomised trial data. Coverage in school-based treatment and community-wide treatment in ten rounds of mass drug administration done 
from 2012 to 2017 was assessed by the Zanzibar Ministry of Health and within our cluster-randomised trial. Calculation of coverage is described in detail in Knopp et al 2016.18
Table 4: Praziquantel treatment coverage in 90 study schools and shehias
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The study is registered with the ISRCTN, number 
48837681.
Role of the funding source
The SCORE secretariat was involved in the trial design. 
The funder of the study had no role in data collection, 
data analysis, data interpretation, patient recruitment, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
The study flow and baseline characteristics are indicated 
in figure 1. The timeline and frequency of all interventions 
and surveys are illustrated in figure 2. 291 shehias were 
assessed for eligibility and 45 shehias on each island 
were randomly allocated to one of three study arms. At 
baseline, 2853 schoolchildren aged 9–12 years were 
surveyed from 30 schools in arm 1, 2688 children from 
29 schools in arm 2, and 2613 children from 29 schools 
in arm 3. In arms 2 and 3, a non-randomised school was 
surveyed, and hence, excluded from further analyses. At 
the endline survey, 3184 children aged 9–12 years were 
surveyed from 30 schools in arm 1, 3217 children from 
30 schools in arm 2, and 3080 children from 29 schools 
in arm 3. In arm 3, one school was lost to follow-up since 
it was transformed into a secondary school. Table 1 
indicates between-group differences of the S haematobium 
prevalence in arm 1 (4∙2%) and in arm 2 (7∙8%), or in 
arm 3 (6∙4%), of the AM egg counts per 10 mL urine in 
arm 1 (2∙8 eggs) and in arm 2 (5∙7 eggs), or in arm 3 
(5∙3 eggs), and of the percentage of heavy infection 
intensities in arm 1 (0∙9%) and in arm 2 (1∙8%), or in 
arm 3 (2∙0%). The trial arms were balanced with respect 
to age and sex of the participants.
Table 2 indicates the reduction in prevalence and 
intensity of infection. The overall S haematobium 
prevalence was reduced from 6∙1% in 2012 to 1∙7% in 
2017, which represents a relative reduction of 72∙3%. The 
percentage of schools with zero infections increased 
from 17 (19%) of 88 in 2012 to 42 (47%) of 89 in 2017. In 
2017, prevalences within schools ranged from 0% to 
10∙7% (median 0∙9%, IQR 0–2∙4%). Although most of 
the 45 schools on each island considerably reduced the 
prevalence of S haematobium from 2012 to 2017, in some 
years and in some schools prevalences increased 
compared with the previous year (figure 3). The grand 
(mean of means) mean of the AM egg counts per 10 mL 
urine at school level was reduced from 4∙7 eggs in 2012 
to 1∙2 eggs in 2017. The percentage of schools with heavy 
infection intensities affecting less than 1% of pupils 
increased from 54 (61%) of 88 in 2012 to 81 (91%) of 
89 in 2017.
In 2017, the S haematobium prevalence decreased to 
1∙4% with MDA alone, 1∙7% with MDA plus snail 
control, and 1∙9% with MDA plus behaviour change. 
The generalised estimating equations revealed no 
significant differences between the prevalence of 
S haematobium with MDA plus snail control (odds ratio 
[OR] 1∙21, 95% CI 0∙6–2∙7) or MDA plus behaviour 
change (OR 1∙31, 95% CI 0∙6–2∙9) compared with 
biannual MDA alone (table 3). Similarly, no significant 
difference was observed between the infection intensity 
with MDA plus snail control (OR 0∙93, 95% CI 0∙3–3∙3) 
or with MDA plus behaviour change (OR 1∙44, 95% CI 
0∙4–4∙4) compared with MDA alone. Adjusting for age, 
sex, and cluster weights did not change the point or 
interval estimates note worthily (table 3). Intra-class 
correlation was estimated at 0∙35.
The results of exploratory analysis by means of different 
models to adjust for imbalance in S haematobium 
prevalence at baseline suggested a greater effect of snail 
control compared with MDA alone with consistent OR 
estimates ranging from 0∙63 to 0∙65. However, 95% CIs 
were broad and the difference not significant (table 3). 
Likewise, behaviour change intervention showed slight 
improvements but the point estimates were less 
consistent and closer to unity (OR: 0∙82–1∙06).
In MDA rounds 1, 2, 3, and 5 on both islands and in 
Unguja also in round 6, children were targeted by CWT. 
Table 4 shows that the coverage in these rounds, stratified 
by study arm, ranged from 63∙8% to 86∙6% as 
determined by NTD Programme staff. In rounds 4, 7, 8, 
9, and 10 on both islands and in Pemba also in round 6, 
children received praziquantel by SBT. The coverage of 
SBT ranged from 72∙2% to 90∙4% when assessed by 
NTD Programme staff and from 69∙8% to 98∙1% in the 
trial coverage surveys.
In the 15 shehias in Pemba, snail control was applied 
in a large and constant number of HWCSs identified and 
visited from 2012 until 2016 (table 5). Annual niclosamide 
coverage in HWCSs with Bulinus spp ranged from 
2012 2013 2014 2015 2016
Unguja
Human water contact sites 39 40 91 105 111
Human water contact sites 
with Bulinus spp
29 (74·4%) 22 (55·0%) 47 (51·7%) 35 (33·3%) 50 (45·1%)
Treated human water contact 
sites with niclosamide when 
Bulinus spp was found
9 (31·1%) 19 (86·4%) 33 (70·2%) 29 (82·9%) 36 (72·0%)
Total Bulinus spp collected 1716 565 676 221 785
Total Bulinus spp shedding 0 13 17 0 5
Pemba
Human water contact sites 140 139 143 143 139
Human water contact sites 
with Bulinus spp
45 (32·1%) 46 (33·1%) 45 (31·5%) 42 (29·4%) 29 (20·9%)
Treated human water contact 
sites with niclosamide when 
Bulinus spp was found
38 (84·0%) 43 (93·5%) 42 (93·3%) 41 (97·6%) 26 (89·7%)
Total Bulinus spp collected 2599 788 795 1012 384
Total Bulinus spp shedding 4 4 1 0 0
Table 5: Snail control coverage in 15 intervention shehias on each of the two study islands
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2012 2013 2014 2015 2016 2017
Total numbers for Pemba
Students registered in 15 public primary schools 16 846 NA NA NA NA 17 152
School-based KDEs 15 15 15 15 15 0
Students attending KDE 1–5
KDE 1 (2012) 14 364 ·· ·· ·· ·· ··
KDE 2 (2013) ·· 14 120 ·· ·· ·· ··
KDE 3 (2014) ·· ·· 15 232 ·· ·· ··
KDE 4 (2015) ·· ·· ·· 14 923 ·· ··
KDE 5 (2016) ·· ·· ·· ·· 16 843 ··
Classroom-based, interactive teaching No Yes Yes Yes Yes Yes
Community-level behaviour change education meetings 37 30 49 42 49 0
People attending meetings 3160 3289 5581 7071 4191 ··
Urinals constructed 0 30 0 0 0 0
Urinals being used NA NA NA NA NA 5
Washing platforms constructed 0 0 6 15 0 ··
Washing platforms being used ·· ·· 6 21 20 18*
Madrassa schools involved in intervention ·· ·· 15 15 54 ··
Madrassa teachers trained in intervention ·· ·· 53 56 82 ··
Madrassa students registered in exposed Madrassas ·· ·· 3591 2066 5735 ··
Madrassa KDEs ·· ·· 15 10 54 ··
Madrassa students attending KDE 1–3
KDE 1 (2014) ·· ·· 3129 ·· ·· ··
KDE 2 (2015) ·· ·· ·· 923 ·· ··
KDE 3 (2016) ·· ·· ·· ·· 4191 ··
Total numbers for Unguja
Students registered in 15 public primary schools 14 887 NA NA NA NA 12 314†
School-based KDEs 6 16 15 12 13 ··
Students attending KDE 1–7
KDE 1 (2012) 5995 ·· ·· ·· ·· ··
KDE 2 (2013) ·· 6358 ·· ·· ·· ··
KDE 3 (2013) ·· 6248 ·· ·· ·· ··
KDE 4 (2014) ·· ·· 13 309 ·· ·· ··
KDE 5 (2014) ·· ·· 12 625 ·· ·· ··
KDE 6 (2015) ·· ·· ·· 9886 ·· ··
KDE 7 (2016) ·· ·· ·· ·· 9577 ··
Classroom-based, interactive teaching No Yes Yes Yes Yes Yes
Community-level behaviour change education meetings 0 42 41 60 26 ··
People attended meetings ·· 988 714 3267 2580 ··
Urinals constructed 0 28 0 0 0 ··
Urinals being used ·· NA NA NA 3 ··
Washing platforms constructed 0 0 3 22 0 ··
Washing platforms being used ·· NA NA NA 19‡ ··
Madrassa schools involved in intervention 0 0 0 15 55 ··
Madrassa teachers trained in intervention 0 0 0 100 226 ··
Madrassa students registered in exposed Madrassas ·· ·· ·· 4507 8647 ··
Madrassa KDEs 0 0 0 22 53 ··
Madrassa students attending KDE 1–2
KDE 1 (2015) ·· ·· ·· 4217 ·· ··
KDE 2 (2016) ·· ·· ·· ·· 4106 ·· 
NA=not assessed. KDE=Kichocho Day Event. *Two washing platforms had no water and one needed minor repair. †One public primary school closed before the end of the 
study and changed the school type to secondary school only. ‡The six platforms were not used because the safe water source nearby was no longer functioning (wells dried; 
tap water has been cut).
Table 6: Behaviour change activities in 15 intervention schools and shehias on each of the two study islands
Articles
e1127 www.thelancet.com/lancetgh   Vol 7   August 2019
84∙0% to 97∙6%. In Unguja, additional HWCSs were 
identified every year. Coverage of infested HWCSs 
ranged from 31∙1% to 86∙4%.
The school-based and classroom-based interventions 
for behaviour change reached annually several thousand 
children registered in schools or madrassas in Pemba 
and Unguja (table 6). The washing platforms installed in 
2014 and 2015 were used frequently by all sexes and 
agegroups. The urinals were not frequently used, 
probably because of lack of maintenance by the 
community, and rapidly fell into disrepair.
Discussion
Over the past decades, examples from several countries 
and areas have shown that elimination of schistosomiasis 
is feasible. Countries having achieved interruption of 
transmission reported economic improvements, the 
integrated use of MDA, intermediate host snail control, 
or improved access to WASH.5 We assessed the effect of 
snail control and behaviour change interventions on top 
of biannual praziquantel MDA for the reduction of 
S haematobium prevalence and infection intensity among 
9–12-year-old children from Zanzibar, one of the first 
settings in sub-Saharan Africa where interruption of 
transmission seems to be a feasible goal, in a 5-year 
repeated cross-sectional cluster-randomised open-label 
trial. Three key messages emerged from our results. 
First, biannual MDA alone or in combination with snail 
control or behaviour change interventions substantially 
reduced the overall S haematobium prevalence and 
infection intensities and eliminated schistosomiasis as a 
public health problem from most areas in Zanzibar. 
Second, biannual MDA was not sufficient to interrupt 
transmission in 5 years, even if accompanied by 
additional measures at small scale. Third, there was 
considerable spatial and temporal heterogeneity of 
infections.
Of note, although snail control or behaviour change 
activities did not significantly boost the effect of biannual 
MDA over the time of the project and at the scale used, 
they might contribute to further reducing prevalence and 
enhance interruption of transmission when tailored to 
focal endemicity, implemented with high coverage and 
good access to WASH, and applied for a longer period.
The following main challenges should be considered. 
Although MDA coverage was high in schools, it was low 
in the community. Non-covered or non-complying 
individuals might have served as a reservoir of infection 
contributing to continued transmission. Cure rate 
(73∙6%) and egg reduction rate (94∙7%) of praziquantel 
against S haematobium are not perfect.23 People are 
mobile and might have acquired infection in a 
neighbouring shehia without snail control interventions. 
Focal application and sporadic coverage of HWCSs with 
niclosamide to minimise environmental effect does not 
prevent snails from repopulating the treated freshwater 
bodies quickly, maintaining the possibility of parasite 
transmission. Behaviour change needs time to initiate 
and adopt, and requires access to child-friendly WASH.
Although not as obvious as persistent hotspots in other 
studies,24,25 some pockets with high risk of transmission 
remained on both islands. These were characterised by a 
large number of HWCSs containing intermediate host 
snails and being located in close proximity to schools or 
settlements.19,26 In such high-risk ecological settings, MDA 
alone might suppress transmission only partially.27 
Continuing towards the end game of elimination, these 
areas will need targeted integrated interventions applied 
with high coverage. To prevent a re-emergence of infection 
in low-risk and zero-prevalence areas, new tools and 
strategies tailored to the changing endemic landscape that 
detect cases and transmission spots with a high sensitivity 
and trigger interventions that are accepted by a mostly 
non-infected community are needed. Moving from 
schistosomiasis control towards elimination as a public 
health problem and interruption of transmission will 
require an adaptive strategy, progressing from widespread 
MDA towards selective interventions and surveillance-
response mechanisms.6,9,28,29 Translational research to 
assess the feasibility of combined interventions in hotspot 
and adequate surveillance-response approaches in low-
endemicity areas might provide evidence on how to 
sustain and further advance the gains made to date, with 
the ultimate goal of reaching interruption of transmission.
Limitations of our study are that our intervention units 
were randomly allocated before and not after assessment 
of the baseline prevalence. Given the low prevalence at the 
endline survey, our trial was not powered to detect small 
but biologically important effects as significant differences. 
Owing to the very low number of positive individuals in 
this elimination setting, a sufficiently large cluster and 
participant number was operationally not feasible.17 Urine 
filtration and reagent strip methods are not highly 
sensitive, particularly if infection intensities are very 
light.30 Use of more rigorous diagnostic approaches and 
tests with higher sensitivity would probably have resulted 
in a higher S haematobium prevalence and a clearer 
picture of the real effect of interventions.31 Moreover, all of 
the interventions were implemented and intensified over 
time and readily available only in 2015. Since we did not 
assess the abundance and infection of intermediate host 
snails in shehias outside the snail control arm, it was not 
possible to compare the number of infected snails across 
the different arms. As streams and water bodies might 
run and extend through different shehias, a future control 
strategy for the whole island should consider treating 
HWCSs along the whole course of the water body 
irrespective of the shehia boundaries. Self-reported 
behaviour change was qualitatively assessed in children 
by visiting schools in arms 1, 2, and 3 through a mixed 
methods study at the end of the project (manuscript 
in preparation). Children targeted by behavioural 
interventions reported now taking praziquantel during 
MDA, and having stopped bathing and washing in 
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the river more frequently than children from the other 
arms (manuscript in preparation). Hence, although 
no significant difference of added snail control or 
behavioural change interventions compared with MDA 
alone was detected in the extremely low S haematobium 
prevalences in our endline survey, the effect of these 
interventions might be reflected elsewhere.
Urogenital schistosomiasis was eliminated as a public 
health problem from Zanzibar in more than 90% of 
the shehias included in the study, but transmission is 
not yet interrupted and reinfection occurs. It is now 
necessary to build on the experience gained in the trial, 
to focus on reducing prevalence in the remaining 
hotspot areas by biannual MDA plus additional 
measures implemented with high coverage, and at the 
scale needed, and to introduce new surveillance-
response approaches so that the important gains can be 
maintained and advanced.
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